Method Development & Validation CDMOs

CD Formulation

United States

CD Formulation provides formulation development, analytical services, drug packaging, and pharmaceutical excipient solutions for pharmaceutical and biotechnology companies. The company offers contract manufacturing and contract research services including liposome cGMP manufacturing, accelerated stability studies, and a wide range of formulation types including oral solid, injectable, and topical formulations. They also supply pharmaceutical excipients and active pharmaceutical ingredients.

Cellab CDMO

Andorra

Cellab CDMO is a Contract Development and Manufacturing Organization based in Andorra, specializing in Advanced Therapy Medicinal Products (ATMPs) including cell and gene therapies. The company provides end-to-end services from concept and early-stage development through clinical programs and commercialization under GMP. Cellab supports therapy developers with an agile approach to accelerate ATMP development from bench to bedside.

CellEasy

France

Cell-Easy (CellEasy) is a French CDMO specializing in GMP cell therapy manufacturing, supporting academic laboratories, biotechs, and pharma companies through development and clinical programs. The company has manufactured over 1,000 clinical doses in its GMP facility and has handled 15+ cell types including T cells, NK cells, T regs, MSCs, iPSCs, and immortalized cell lines across 50+ development programs. Cell-Easy follows ICH Q2(R1), European Pharmacopoeia, EMA/MHRA, and US Pharmacopoeia standards.

Cellistic

Belgium

Cellistic is a Belgium-based CDMO specializing in iPSC-based cell therapy manufacturing, positioned as a global leader in allogeneic iPSC-derived cell therapy production. The company offers full-spectrum manufacturing services including cell line development, process development, GMP manufacturing platforms, ready-to-use iPSC lines, and proprietary gene-editing capabilities. Cellistic operates Europe's first facility dedicated exclusively to iPSC-based cell therapy development and manufacturing in Mont-Saint-Guibert, Belgium.

Celonic

Germany

Celonic is a Swiss-based 'Pure Play' biologics CDMO offering end-to-end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics, and other complex molecules. The company is a pioneer in next-generation bioprocessing technologies including process intensification and full perfusion. Celonic operates facilities in Basel, Switzerland and Heidelberg, Germany, and has a strategic alliance with CARBOGEN AMCIS for integrated ADC development and manufacturing.

Cenexi

Belgium

Cenexi is a Belgian/French CDMO specializing in sterile products, biological and injectable pharmaceutical manufacturing. The company operates four manufacturing sites in Europe, including sites in Fontenay-sous-Bois and Herouville-Saint-Clair (France), Osny (France, for highly active solid pharmaceutical forms), and Belgium. Cenexi offers services from development to commercial production for pre-filled syringes, vials, lyophilized products, tablets, capsules, and syrups, with FDA-registered manufacturing operations.

Center for Breakthrough Medicines (CBM)

United States

Center for Breakthrough Medicines (CBM) is a cell and gene therapy CDMO based in King of Prussia, Pennsylvania, operating at The Discovery Labs campus. CBM offers comprehensive services including plasmid manufacturing (Precision Plasmids), viral vector manufacturing (Genesis Vector Manufacturing Solutions), cell therapy manufacturing, and analytical testing (Analytical Accelerator for AAV testing). SK Pharmteco acquired controlling interest in CBM, and the company has capacity to manufacture therapies for 10,000+ patients.

Centre c3i

Canada

C3i Center Inc is the first CDMO in Canada to receive approval for a Drug Establishment License to commercially produce cell therapy drug products. Based in Montreal, the company provides tailored cell and gene therapy CDMO services from development through commercial manufacturing.

Cerbios‑Pharma SA

Switzerland

Cerbios-Pharma SA is a privately held Swiss CDMO based in Barbengo-Lugano with over 40 years in the pharmaceutical industry, now part of the HAS Group. The company specializes in the development and manufacture of chemical and biotechnological APIs, with particular expertise in HPAPIs (high-potency APIs), ADC payloads and conjugation, and recombinant proteins and antibodies. Cerbios offers both chemical synthesis and biological manufacturing capabilities, including living microorganism-based products.

ChemPartner

China

ChemPartner is a science-based, technology-driven global CRO and CDMO with over 20 years of experience and 2,000+ scientists. The company provides end-to-end drug discovery through IND services for small molecules and biologics, including antibody discovery, ADC development, and cGMP biologics manufacturing. ChemPartner has expanded its biologics CDMO capabilities with a 67,000 sqm facility in Qidong, China and a new R&D center in Boston.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)

Taiwan

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), founded in 1964 and operating as Cenra API Solutions, is one of the largest API manufacturers in Taiwan. The company provides cGMP toll manufacturing and contract research services with FDA/EU-approved facilities, producing APIs across antifungal, immunosuppressant, oncology, cardiovascular, and peptide drug categories.

Coating Place Inc

United States

Coating Place Inc is a Wisconsin-based pharmaceutical CDMO founded in 1976, specializing in Wurster fluid bed coating technology for oral solid dosage forms. The company operates FDA- and EMA-approved GMP facilities in Verona and Sauk City, Wisconsin, with 24 proprietary Wurster fluid bed coaters handling batches from 0.010 kg to 800 kg, and is DEA-licensed for Schedule I-V controlled substances. The company celebrated its 50th anniversary in 2026.

Codexis, Inc.

United States

Codexis, Inc. is a US-based enzyme engineering and biocatalysis company that provides contract manufacturing of RNA therapeutics through its ECO Synthesis Manufacturing Platform, as well as pharmaceutical biocatalysis services for small molecule API manufacturing. The company uses proprietary enzyme-enabled platforms to deliver enzymatic RNA synthesis (siRNA, mRNA) as an alternative to traditional chemical synthesis, offering higher purity, yield, and sustainability.

Codis

United States

Codis is a global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK facility previously operated by EUROAPI, the company operates over 400,000 sq ft of cGMP manufacturing space across three sites with a 30-year regulatory track record, and is the world's leading manufacturer of Sevelamer API producing hundreds of metric tons annually.

CorePharma LLC

United States

CorePharma LLC, founded in 1998 and headquartered in Middlesex, NJ, is a CDMO specializing in oral solid dosage forms including IR and ER tablets and capsules. The company offers end-to-end services from product development and contract manufacturing to packaging and analytical testing, with cGMP-compliant FDA & DEA registered facilities producing over 2 billion units annually.

CPC Scientific Inc.

China

CPC Scientific Inc. is a CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in peptide and oligonucleotide production and therapeutic development. The company offers GMP peptide and oligonucleotide manufacturing from Phase I through commercial scale, with facilities in the US (Rocklin, CA) and China.

CRAMSN Research Park

India

CRAMSN Research Park is an India-based contract research, development, and manufacturing organization offering end-to-end CRO, CDMO, and CMO solutions. The company provides drug substance (API) and drug product manufacturing with multiple facilities in India and a facility in New Jersey, USA, committed to sustainable practices including green chemistry and solar-powered operations.

Creative Biolabs

United States

Creative Biolabs is a US-based ISO 9001:2015 certified CDMO providing comprehensive biotechnology and pharmaceutical services including antibody discovery, viral vector CDMO solutions, CAR-T cell therapy manufacturing, and custom bio-manufacturing. The company offers end-to-end services from discovery through cGMP production for biologics including AAV, lentivirus, adenovirus, and HSV vectors.

Crystal Pharmatech

Canada

Crystal Pharmatech is a global pharmaceutical CRO/CDMO headquartered in Canada specializing in solid-state research, advanced formulation development, and GMP manufacturing for small molecule drugs. The company offers a First-Time-Right 3-STEP approach from API form selection through crystallization development to clinical and commercial manufacturing, with sites in Canada, the US, and China.

Custom Pharma Services

United Kingdom

Custom Pharma Services is a UK-based CDMO founded in 1979 in Brighton, specializing in oral solid dose manufacturing and packaging for clinical and commercial use. The company is MHRA-approved and FDA-inspected, with capacity exceeding 1.5 billion tablets and 250 million capsules annually. Custom Pharma handles controlled drugs, hormonal products, and has launched Centrix Pharma Solutions for early-stage development.

Dalton Pharma Services

Canada

Dalton Pharma Services is a Canadian CDMO and subsidiary of Seikagaku Corporation Japan, providing integrated drug discovery, development, and manufacturing services. The company is FDA-inspected and Health Canada-approved with over 35 years of experience, specializing in custom chemical synthesis, cGMP API manufacturing, sterile vial filling, and formulation development including liposomal formulations. Dalton recently announced major expansion of its commercial sterile manufacturing capacity.

Danhson

Bulgaria

Danhson is a Bulgaria-based pharmaceutical holding company established in 2015, with group companies including Vetprom AD (65+ years of manufacturing history) and Danapha Pharmaceutical in Vietnam. The company develops, produces, and markets pharmaceutical products (Rx and OTC), food supplements, and cosmetics, with CMO/CDMO services. Danhson has invested BGN 50 million in a new production site with separate workshops for ampoule forms, liquid forms, semisolid, and biological products.

Davipharm

Vietnam

Davipharm (Dat Vi Phu Pharmaceutical JSC) is a Vietnamese pharmaceutical manufacturer and member of the Adamed group, holding EU GMP certification. The company manufactures over 300 generic drug products at its facility in Binh Duong, Vietnam, and offers CMO/CDMO services including high-potency drug manufacturing. Davipharm recently expanded its capacity and capabilities in high-potency manufacturing.

Deccan Nutraceuticals Pvt. Ltd. (DNPL)

India

Deccan Nutraceuticals Pvt. Ltd. (DNPL) is an Indian API manufacturer and group company of Alkaloids Corporation, primarily producing active pharmaceutical ingredients, intermediates, and botanical/phytopharmaceutical extracts. Operating from a 22,000 sqm FDA-authorized, USFDA and EDQM inspected facility, DNPL has a portfolio of over 100 products including plant-based, semi-synthetic, and synthetic APIs. The company exports to major markets including USA, EU, Australia, and Canada.

Delpharm

Canada

Delpharm is one of the world's top five CDMOs, specializing in the development and manufacture of medicines across solid, sterile, semi-solid, and liquid dosage forms with particular expertise in nasal sprays and injectables. The company operates 18 manufacturing sites and 3 development centers across Europe and North America, with 6,500 employees and over 1.1 billion EUR in turnover. Delpharm produces over 650 million units annually and recently received a $60 million Canadian government investment to modernize its Boucherville injectable facility.

DifGen Pharmaceuticals

United States

DifGen Pharmaceuticals is a US-based CDMO specializing in complex generics and advanced drug delivery systems, providing end-to-end solutions from product development through commercial manufacturing. Through its 2023 acquisition of Aveva Drug Delivery Systems Inc., DifGen gained a 455,000 sq. ft. US manufacturing footprint producing over 300 million transdermal patches annually, including controlled substances like buprenorphine transdermal systems.

Dragon Sail Pharmaceutical

China

Dragon Sail Pharmaceutical Co., Ltd. is a Chinese CDMO founded in 2016, focusing on antibody drug CDMO/CMO services from sequence to IND through commercial production. The company built China's first cross-free antibody plant in the Shanghai Lin-gang Special Area with a total investment of nearly RMB 700 million and a maximum production scale of 12,000L.

Eckert & Ziegler

Germany

Eckert & Ziegler is a leading German specialist in isotope-related components for nuclear medicine and radiation therapy with over 1,000 employees. The company's Radiopharma division serves as a CMO for clinical and commercial supply of radiopharmaceuticals using alpha, beta, or gamma radiation, including Lutetium-177, Yttrium-90, Gallium-68, Actinium-225, and Thorium-227 products.

Emil Pharmaceutical Industries Pvt Ltd

India

Emil Pharmaceutical Industries Pvt. Ltd. is an Indian CDMO founded in 1989, headquartered in Mumbai with three manufacturing units in MIDC Tarapur, Maharashtra. The company manufactures pharmaceuticals, nutraceuticals, and OTC formulations including tablets, capsules, powders, liquids, creams, and ointments. Emil has partnered as a CDMO with global companies including Abbott, Mylan, Pfizer, GSK, USV, and MSD, and exports to over 25 countries with certifications from WHO, ISO 9001, NAFDAC Nigeria, and FDA Ghana.

ENABLE Biotech Ltd (Switzerland)

Switzerland

ENABLE Biotech is a Swiss CDMO specializing in cell and gene therapy manufacturing for clinical-stage companies. The company operates from a SwissMedic-accredited GMP facility with Grade C production rooms equipped with Grade A isolators, focusing on phase-appropriate CMC expertise at attractive pricing for first-in-human production.

Enable Innovations S.r.l.

Italy

Enable Innovations is an Italian contract manufacturer specializing in the aseptic preparation and filling of sterile liquid products, particularly eye drops, nasal sprays, and inhalation solutions. Founded in 2009 in Carpi, Italy, the company operates fully automated production lines for medical devices, food supplements, and foods for special medical purposes.

ENCell Co., Ltd.

South Korea

ENCell Co., Ltd. is a South Korean biotechnology company and CDMO specializing in cell and gene therapy, founded in 2018 as a spin-off from Samsung Medical Center. The company operates three separate GMP facilities and provides end-to-end pharmaceutical development services from R&D to regulatory approval, including drug substance/product manufacturing and contract quality testing.

Enzene Biosciences Limited

India

Enzene Biosciences is an Indian CDMO and subsidiary of Alkem Laboratories, specializing in biologics and biosimilar development and manufacturing. The company's patented EnzeneX continuous bioprocess manufacturing platform significantly reduces the cost of producing complex biologics and monoclonal antibodies, with facilities in Pune, India and an expanding site in Hopewell, New Jersey, USA.

Experic

United States

Experic is a US-based CDMO headquartered in Cranbury, NJ, specializing in pharmaceutical development, powder handling, inhalation drug products, and clinical trial supply packaging. The company has expanded its analytical laboratory capabilities and opened a facility in Dublin, Ireland to support global clinical trials.

Forge Biologics (Ajinomoto Group)

United States

Forge Biologics, acquired by Ajinomoto Group in 2023 for $554-620 million, is a gene therapy CDMO specializing in high-purity adeno-associated virus (AAV) vector and plasmid manufacturing. The company operates a 200,000 sq ft Hearth facility in Columbus, Ohio with 20 cGMP suites and 20,000L bioreactor capacity, providing end-to-end services from preclinical process development through commercial manufacturing.

Fortis Life Sciences

United States

Fortis Life Sciences is a CDMO partner to diagnostics and life science companies, offering an integrated portfolio of reagents, components, and service solutions. The company provides antibody development and manufacturing, conjugation services, lyophilization, cell and gene therapy support, and diagnostic assay CDMO services.

Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Germany

The Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig is a contract research and GMP manufacturing institute specializing in cell and gene therapy, vaccines, and biologics. The institute provides GMP-compliant manufacturing of clinical trial materials (ATMPs and biologicals), process development for pharmaceutical manufacturing, and regulatory support for manufacturing authorizations and approvals.

Gannet BioChem

United States

Gannet BioChem is a specialty CDMO based in Huntsville, Alabama, focused on polymer science, PEG chemistry, and bioconjugation. Built on the legacy of Shearwater Polymers and Nektar Therapeutics, the company provides end-to-end capabilities from early discovery through cGMP and commercial manufacturing of activated polymers, PEG reagents, and bioconjugates. The FDA-inspected facility spans over 124,000 square feet across four buildings and has supported 50+ global partners.

GL Biochem (Shanghai) Ltd.

China

GL Biochem (Shanghai) Ltd. is a peptide and API contract development and manufacturing organization founded in 2001. The company specializes in custom peptide synthesis, peptide APIs, and small molecule API manufacturing, with FDA- and EU GMP-registered facilities in Shanghai. It serves global pharmaceutical clients with products ranging from research-grade peptides to cGMP commercial-scale production.

Glenmark (incl. API arm Glenmark Life Sciences)

Argentina

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company focused on branded and generic formulations, with an API manufacturing arm called Glenmark Life Sciences. The company manufactures APIs and finished dosage forms primarily for its own portfolio, spanning dermatology, respiratory, oncology, and cardiovascular therapeutic areas. Glenmark Life Sciences produces over 120 APIs across multiple manufacturing sites in India.

Global Pharma HealthCare (India)

India

Global Pharma HealthCare is an Indian pharmaceutical CDMO offering contract development and manufacturing services for sterile and non-sterile dosage forms. The company provides end-to-end services from formulation development through commercial manufacturing, including oral solids, liquids, sterile injectables, and lyophilized products. It serves regulated markets including the US, EU, and other global markets.

Globela Pharma Pvt Ltd

India

Globela Pharma Pvt Ltd is an Indian pharmaceutical company founded in 2006, offering CDMO, CRAMS, and API manufacturing services. The company has specialized EU GMP-certified facilities for oncology (cytotoxic) and cephalosporin manufacturing, with a DSIR-approved R&D center and exports to over 50 countries. It provides end-to-end services from API and intermediate manufacturing through finished dosage form production.

GP Pharm S.A.

Spain

GP Pharm S.A. is a Spanish CDMO specializing in sterile injectable manufacturing, with particular expertise in long-acting injectable depot formulations including microspheres and sustained-release systems. The company offers contract development and manufacturing services from formulation development through commercial production, with capabilities in aseptic processing, fill/finish for vials and pre-filled syringes, and lyophilization.

Granules (Granules India)

India

Granules India Limited is a vertically integrated pharmaceutical company and CDMO specializing in high-volume oral solid dosage manufacturing from APIs through finished dosage forms. The company is one of the largest manufacturers of core molecules such as paracetamol, metformin, guaifenesin, and ibuprofen, operating multiple FDA- and EU GMP-approved manufacturing facilities across India and the US. It provides contract manufacturing services for global pharmaceutical companies.

hameln rds s.r.o.

Slovakia

hameln rds s.r.o., based in Modra, Slovakia, is a well-recognized pharmaceutical CDMO that has been providing services to the healthcare industry since 1972. The company offers analytical and galenical development of pharmaceuticals, QC and laboratory services (including stability testing, batch release, and biologics testing), GMP production of APIs, and regulatory affairs support. It is FDA-registered with approved injectable products.

Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.

China

Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., founded in 2013 in Hefei City, China, is an ISO 9001:2015 certified manufacturer and supplier of Active Pharmaceutical Ingredients, intermediates, and fine chemicals. The company specializes in APIs for diabetes, oncology, and CNS therapeutic areas, as well as specialized resin products for peptide API production.

Helba İlaç İç ve Dış San. Tic. A.Ş.

Turkey

Helba Pharma is a Turkish pharmaceutical manufacturer established in 2008, with roots in Welfar Pharma founded in Azerbaijan in 1995. The company produces solid and semi-solid form medicines at its GMP-certified production facility with 50 million box manufacturing capacity, and actively exports to CIS countries, Balkans, and Middle Eastern markets.

Helix Biotech, Inc.

United States

Helix Biotech, Inc. is a U.S.-based CDMO specializing in GMP formulation and RNA manufacturing, including DNA, RNA, and LNP (lipid nanoparticle) formulations. The company offers end-to-end services from RNA construct design through its StrandSolve platform to GMP manufacturing via its NOVA IJM nanoparticle formulation platform.